Further, data showed that eNAMPT mAb treatment played a significant role in the upregulation of inflammatory cytokine repressor genes, such as ATF3, FOS, and JUN, and the negative regulation of TLR and the non-canonical NF-κB pathway in the NEC group (Figure 5). This evidence concerns the gene ATF3 and necrotizing enterocolitis.